Popular Articles

PIH Founder Farmer Discussing Possible Appointment To Coordinate U.S. Global Health Initiatives, Boston Globe Reports
Paul Farmer -- founder of Partners in Health and vice chair of the Department of Global Health and Social Medicine at Harvard Medical School -- said he is in discussions with the State Department about a possible Obama administration appointment to coordinate U.S. global health initiatives, the Boston Globe reports. Farmer made the announcement Monday during a meeting with HMS faculty. Farmer said that he has not decided whether he will accept the appointment if he receives a formal offer but that he is considering it, according to the Globe. The Globe reports that it was unable to confirm whether Farmer is being considered for a full-time policy position or for an advisory role or if the appointment would be a new or existing position. Several top positions at USAID -- including administrator, deputy administrator and the assistant administrator in charge of global health are vacant, the Globe reports. These positions are presidential appointments and would require Senate confirmation. In addition, Farmer could be discussing health policy positions with the State Department. Farmer did not respond for requests seeking comment. PIH and HMS also declined comment. A spokesperson at the State Department would not discuss personnel discussions that are in progress or possible new positions. Laurie Garrett, a global health policy specialist at the Council on Foreign Relations, said the administration"s announcement last week of a $63 billion, six-year initiative that aims to address HIV/AIDS, tuberculosis, malaria and other illnesses could allow new appointees the opportunity to make a significant impact in U.S. global health policy. Garrett, who has known Farmer for several years, added that she would be surprised if he is considering a government position in part because of his extensive involvement with PIH (Smith, Boston Globe, 5/15).
generic viagra
In Chronic Viral Infection Immune Exhaustion Driven By Antigen
One main reason why viruses such as HIV or hepatitis C persist despite a vigorous initial immune response is exhaustion. The T cells, or white blood cells, fighting a chronic infection eventually wear out.
News of the day
Spectranetics Receives CE Mark Approval For ThromCat(R)XT
Spectranetics Corporation (Nasdaq:SPNC) reported that it has received the CE mark approval for its next-generation ThromCat® XT Thrombus Removal System, a single-use, disposable device indicated for mechanical removal of thrombus from native coronary arteries and infra-inguinal arteries. The launch of the product will commence immediately within the European Union. The approval triggers a milestone payment of $1.5 million pursuant to the Company"s Amended Development and Regulatory Services agreement with Kensey Nash Corporation (Nasdaq:KNSY).
Cardiovascular

Patient Recall Rates May Be Decreased By Digital Mammography Plus Digital Breast Tomosynthesis

Nationally, about ten percent of women in the US are recalled for a second mammogram after an abnormality is detected on the first one - for most women this can be very stressful. However the use of digital breast tomosynthesis and full-field digital mammography combined may be associated with a substantial decrease in recall rate, according to a study performed at UPMC in Pittsburgh, PA. Some researchers believe that digital breast tomosynthesis depicts the breast tissue in a way which may allow radiologists to identify some tumors which could be missed with standard two-dimensional mammography. The study included 125 patients that were evaluated using a combined method of digital breast tomosynthesis and standard digital mammography. "The use of digital breast tomosynthesis and full-field digital mammography (FFDM) was associated with a 30% reduction in recall rate for cancer-free examinations that would have led to recall if FFDM had been used alone," said Jules H. Sumkin, MD, one of the authors of the study. "Patient recalls are problematic at multiple levels. Patients pay an emotional price and it is a sheer inconvenience having to go back for a second appointment. It is also problematic for imaging facilities because they are faced with the high cost of res required for the recalls," he said. "We are confident that recall rates could be decreased by adding breast tomosynthesis to FFDM," said Dr. Sumkin. Digital breast tomosynthesis is not yet FDA approved. This study appears in the August issue of the American Journal of Roentgenology. Click here for abstract. Heather Curry American Roentgen Ray Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):